Evidence map›Paper›PMID 39091805›Full record

ArticlebioRxiv : the preprint server for biology2024

Intravenous BCG induces a more potent airway and lung immune response than intradermal BCG in SIV-infected macaques.

Solomon Jauro, Erica C Larson, Janelle L Gleim, Brendon M Wahlberg, Mark A Rodgers, Julia C Chehab, Alondra E Lopez-Velazques, Cassaundra L Ameel, Jaime A Tomko, Jennifer L Sakal and 8 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Solomon JauroDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.ORCID 0000-0002-5373-5727
Erica C LarsonDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.ORCID 0000-0001-5025-9369
Janelle L GleimDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
Brendon M WahlbergDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
Mark A RodgersDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
Julia C ChehabDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
Alondra E Lopez-VelazquesDepartment of Biology, University of Puerto Rico - Humacao Campus, Puerto Rico, USA.
Cassaundra L AmeelDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
Jaime A TomkoDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
Jennifer L SakalDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
Todd DeMarcoHuman Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
H Jake BorishDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
Pauline MaielloDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
E Lake PotterVaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Mario RoedererVaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Philana Ling LinCenter for Vaccine Research, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
JoAnne L FlynnDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
Charles A ScangaDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.ORCID 0000-0003-3654-5603

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Practices CoreUC7AI180311 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI William Paul Duprex · 2023 to 2026
$13.2M
Preventing TB with intravenous BCG in SIV-infected macaquesR01AI155345 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SCANGA, CHARLES A. · 2021 to 2025
$4.2M
Re-educating T cell-mediated immunity in SIV by modulating metabolic pathwaysK01OD033539 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LARSON, ERICA CHRISTINE · 2022 to 2024
$571k
NIAID NIH HHS HHSN272201800003CNIAID NIH HHS R01 AI155345NIAID NIH HHS UC7 AI180311NIH HHS K01 OD033539NIH HHS P51 OD011107
6 · The paper itself

Abstract

Tuberculosis (TB), caused by

Identifiers

PMID39091805
PMCPMC11291007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.